- Chemoresistant myeloid sarcoma responding to salvage therapy with combined azacitidine and venetoclax2022 | First Faculty of Medicine
- New therapeutic approaches and perspectives in the treatment of myelodysplastic syndrome2019 | First Faculty of Medicine
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study2009 | Publication without faculty affiliation
- Zpráva z posledních analýz terapie Vidazou (azacitidin) a Revlimidem (lenalidomid) nemocných s myelodysplastickým syndromem v ČR - data z MyDyS registru2019 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II2013 | First Faculty of Medicine
- Treatment strategies for myelodysplastic syndrome in 20212021 | Faculty of Medicine in Hradec Králové
- Sweet Syndrome in a Patient with Myelodysplastic Syndrome - Case Report2017 | First Faculty of Medicine
- Patofyziologické aspekty myelodysplastického syndromu ve vztahu k efektu cílené imunomodulační a demetylační terapiePublication without faculty affiliation